Matrix metalloproteinase-12 contributes to neuroinflammation in the aged brain

Yang Liu1, Min Zhang, Wenlin Hao

  • 1Department of Neurology, University of the Saarland, Homburg/Saar, Germany. a.liu@mx.uni-saarland.de

Neurobiology of Aging
|November 20, 2012
PubMed

Insights

Aging brains show increased inflammation, linked to diseases like Alzheimer's. This study found that reducing Matrix metalloproteinase-12 (MMP-12) lessens this age-related neuroinflammation by controlling inflammatory cell entry.

Area of Science:

  • Neuroscience
  • Immunology
  • Aging Research

Background:

  • The aging brain exhibits heightened inflammation, a factor in neurodegenerative diseases like Alzheimer's and Parkinson's.
  • Matrix metalloproteinases (MMPs) are enzymes that influence inflammatory cell movement and activity within tissues.

Purpose of the Study:

  • To investigate the role of Matrix metalloproteinase-12 (MMP-12) in age-related neuroinflammation.
  • To determine if MMP-12 deficiency impacts the inflammatory status of the aging brain.

Main Methods:

  • Screening of MMP expression in mice of different ages (3, 10, and 18 months).
  • Comparison of neuroinflammation in MMP-12 deficient versus wild-type mice.
  • Analysis of microglia and inflammatory gene transcripts in the brain.
  • Assessment of microglia inflammatory activity in vitro and in vivo.

Main Results:

  • Cerebral MMP-12 expression significantly increases with age in mice.
  • Mice lacking MMP-12 showed reduced neuroinflammation during aging.
  • MMP-12 deficiency enhanced the inflammatory activity of adult microglia but not newborn microglia.
  • Increased recruitment of bone marrow-derived microglia (CD11b/CD45(high) cells) was observed in wild-type brains.

Conclusions:

  • Upregulated MMP-12 in the aging brain exacerbates neuroinflammation.
  • MMP-12 facilitates the recruitment of bone marrow-derived microglia into the brain, contributing to age-associated neuroinflammation.